Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    December 2018
  1. PEREZ-ALVAREZ AI, Garcia-Rua A, Suarez-Santos P, Castanon-Apilanez M, et al
    [Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index].
    Rev Neurol. 2018;67:417-424.
    PubMed     Text format     Abstract available


    November 2018
  2. PEDRAZ B, Sammer G
    The importance of glutamate in the neuro-endocrinological functions in multiple sclerosis, related to fatigue.
    Rev Neurol. 2018;67:387-393.
    PubMed     Text format     Abstract available


  3. ROBLES-CEDENO R, Ramio-Torrenta L
    [Cladribine in the treatment of relapsing multiple sclerosis].
    Rev Neurol. 2018;67:343-354.
    PubMed     Text format     Abstract available


    September 2018
  4. MALLADA-FRECHIN J, Meca-Lallana V, Barrero F, Martinez-Gines ML, et al
    [Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].
    Rev Neurol. 2018;67:157-167.
    PubMed     Text format     Abstract available


    August 2018
  5. LABBE T, Ciampi E, Cruz JP, Zurita M, et al
    Functional magnetic resonance imaging in the study of multiple sclerosis.
    Rev Neurol. 2018;67:91-98.
    PubMed     Text format     Abstract available


    June 2018
  6. JUANATEY A, Blanco-Garcia L, Tellez N
    Ocrelizumab: its efficacy and safety in multiple sclerosis.
    Rev Neurol. 2018;66:423-433.
    PubMed     Text format     Abstract available


  7. EICHAU S, Lopez-Ruiz R, Ruiz-Pena JL, Paramo MD, et al
    [Vitiligo with Koebner phenomenon in a patient with multiple sclerosis treated with alemtuzumab].
    Rev Neurol. 2018;66:395-396.
    PubMed     Text format    


    May 2018
  8. GONZALEZ-GOMEZ A, Garcia-Ben A, Soler-Garcia A, Garcia-Basterra I, et al
    [Analysis of the quantitative differences in the thickness of the retinal nerve fibre layer between time-domain and spectral-domain optical coherence tomography in patients with relapsing-remitting multiple sclerosis].
    Rev Neurol. 2018;66:297-302.
    PubMed     Text format     Abstract available


    April 2018
  9. PEREZ-MIRALLES FC
    Daclizumab in multiple sclerosis.
    Rev Neurol. 2018;66:271-282.
    PubMed     Text format     Abstract available


  10. RIO J
    [New drugs for the treatment of multiple sclerosis].
    Rev Neurol. 2018;66:253.
    PubMed     Text format    


    March 2018
  11. PULIDO I, Gomes I, Rodrigues J, Guerreiro T, et al
    [Multiple sclerosis in continental Portugal: analysis of spatio-temporal clusters and spatial variations in time trends of hospitalised patients between 2002 and 2013].
    Rev Neurol. 2018;66:182-188.
    PubMed     Text format     Abstract available


    January 2018
  12. MIDAGLIA L, Mora L, Mulero P, Sastre-Garriga J, et al
    [Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis].
    Rev Neurol. 2018;66:25-32.
    PubMed     Text format     Abstract available


    September 2017
  13. LOPEZ-ALAVA S, Aliri J, Olascoaga J, Sistiaga A, et al
    [Psychosocial factors and cognitive performance in multiple sclerosis: gender differences].
    Rev Neurol. 2017;65:216-222.
    PubMed     Text format     Abstract available


    August 2017
  14. LANDER B, Alvarado M, Alvarez IC, Armas E, et al
    [Venezuelan consensus guidelines on the use of magnetic resonance in diagnosis and follow up of patients with multiple sclerosis].
    Rev Neurol. 2017;65:117-126.
    PubMed     Text format     Abstract available


    June 2017
  15. JIMENEZ-MORALES RM, Herrera-Jimenez LF, Macias-Delgado Y, Perez-Medinilla YT, et al
    [Cognitive training combined with aerobic exercises in multiple sclerosis patients: a pilot study].
    Rev Neurol. 2017;64:489-495.
    PubMed     Text format     Abstract available


    May 2017
  16. ALCALA-VICENTE C, Perez-Miralles FC, Gascon-Gimenez F, Bosca-Blasco I, et al
    [Treatment of relapsing-remitting multiple sclerosis with fingolimod in routine clinical practice].
    Rev Neurol. 2017;64:445-453.
    PubMed     Text format     Abstract available


    March 2017
  17. ORTIZ P, Bareno J, Cabrera L, Rueda K, et al
    [Magnetic resonance imaging with gadolinium in the acute phase of relapses in multiple sclerosis].
    Rev Neurol. 2017;64:241-246.
    PubMed     Text format     Abstract available


    February 2017
  18. DUQUE P, Oltra-Cucarella J, Fernandez O, Sepulcre J, et al
    [Brief Neuropsychological Battery for multiple sclerosis. Normative data stratified by age and educational level].
    Rev Neurol. 2017;64:97-104.
    PubMed     Text format     Abstract available


    December 2016
  19. COLLADO-VAZQUEZ S, Carrillo JM, Cano-de-la-Cuerda R
    [Multiple sclerosis in literature, cinema and television].
    Rev Neurol. 2016;63:547-556.
    PubMed     Text format     Abstract available


    October 2016
  20. FERNANDEZ JIMENEZ-ORTIZ H, Reche-Sainz JA, Villarrubia-Torcal B, Toledano-Fernandez N, et al
    [Appraisal of the formation of afterimages by means of a new computer application in patients with demyelinating optic neuropathies].
    Rev Neurol. 2016;63:337-344.
    PubMed     Text format     Abstract available


    August 2016
  21. LOPEZ-MARTIN D, Martinez-Anton J
    [Optic neuritis in childhood. A pediatric series, literature review and treatment approach].
    Rev Neurol. 2016;63:103-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: